EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Association Between Coagulation Fibrinolysis Markers and Severity in Patients with COVID-19

Takuya Iwamoto iD, Yuki Hatayama iD, Noriko Yamashita, Hitomi Ichikawa, Koji Kawamura

Clinical and Applied Thrombosis/Hemostasis · 2024

DOI: 10.1177/10760296241298233 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Applied Thrombosis/Hemostasis, 2024. Verfasst von Takuya Iwamoto und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Clinical Laboratory Medicine, Tottori University Hospital, Yonago, Tottori, Japan. Hauptthemen laut MEDLINE: COVID-19, Fibrinolysis, Biomarkers, Severity of Illness Index. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Thrombosis is a major complication of COVID-19. D-dimer (DD) is an important coagulation fibrinolysis marker in COVID-19 and has been extensively studied. However, very little is known about the role of other fibrinolysis markers, plasmin-plasmin inhibitor complex (PIC), and fibrin monomer complex (FMC) in COVID-19. This study investigated and compared the associations of DD, PIC, and FMC with COVID-19 severity.

Methods

Archived plasma samples from patients with COVID-19 (n = 50) were assessed for DD, FMC, and PIC levels. We compared the levels between patients with mild (n = 36) and moderate (n = 14) COVID-19 and evaluated their correlation with other COVID-19 severity markers, including lactate dehydrogenase (LD), serum albumin (Alb), C-reactive protein (CRP), and neutrophil-lymphocyte ratio (NLR).

Results

Patients with moderate COVID-19 had significantly higher DD and PIC levels than those with mild disease, while FMC levels were comparable. DD and PIC levels significantly correlated with LD, Alb, and NLR. Additionally, PIC levels significantly correlated with CRP levels. However, FMC levels correlated only with Alb but not with LD, NLR, or CRP.

Conclusions

COVID-19 severity was significantly associated with PIC and DD levels but not with FMC levels. PIC was the variable with the most clearly significant difference between patients with moderate disease and those with mild disease, highlighting its potential as an indicator of coagulation and fibrinolysis imbalance in patients with COVID-19. Further studies with larger sample sizes and more diverse severity groups are required to confirm these findings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19FibrinolysisBiomarkersSeverity of Illness IndexFibrin Fibrinogen Degradation ProductsSARS-CoV-2Blood CoagulationHumansMaleFemaleMiddle AgedAgedFibrinolysinAdultC-Reactive ProteinThrombosisalpha-2-Antiplasmin

Stichwörter der Autor:innen

COVID-19D-dimerFMCPIC

Substanzen

BiomarkersFibrin Fibrinogen Degradation Productsfibrin fragment Dplasmin-plasmin inhibitor complexFibrinolysinC-Reactive Proteinfibrinmonomeralpha-2-Antiplasmin

Autor:innen und Institutionen

  • Division of Clinical Laboratory Medicine, Tottori University Hospital, Yonago, Tottori, Japan.
  • Department of Multidisciplinary Internal Medicine, School of Medicine, Tottori University Faculty of Medicine, Yonago, Tottori, Japan.
  • Department of Hematology, Tottori University Hospital, Yonago, Tottori, Japan.

ORCID-Profile: Takuya Iwamoto, Yuki Hatayama

Zitieren

APA

Iwamoto, T., Hatayama, Y., Yamashita, N., Ichikawa, H., & Kawamura, K. (2024). Association Between Coagulation Fibrinolysis Markers and Severity in Patients with COVID-19. Clinical and Applied Thrombosis/Hemostasis. https://doi.org/10.1177/10760296241298233

Vancouver

Iwamoto T, Hatayama Y, Yamashita N, Ichikawa H, Kawamura K. Association Between Coagulation Fibrinolysis Markers and Severity in Patients with COVID-19. Clinical and Applied Thrombosis/Hemostasis. 2024. doi:10.1177/10760296241298233

BibTeX
@article{Iwamoto2024,
  author = {Iwamoto, Takuya and Hatayama, Yuki and Yamashita, Noriko and Ichikawa, Hitomi and Kawamura, Koji},
  title = {Association Between Coagulation Fibrinolysis Markers and Severity in Patients with COVID-19},
  journal = {Clinical and Applied Thrombosis/Hemostasis},
  year = {2024},
  doi = {10.1177/10760296241298233}
}
Kostenlos starten →